|Bid||23.4900 x 5000|
|Ask||24.6300 x 100|
|Day's Range||23.9600 - 24.0314|
|52 Week Range||23.4300 - 26.0300|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.80%|
DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut. 97.5% of patients continue treatment in the open-label arm of the REALISE study and will receive active treatment ...
DBV Technologies to Attend Upcoming Investor Conferences. DBV Technologies today announced that members of its management team will present and host investor meetings at the following investor conferences ...
DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-Allergic Patients One to Three Years of Age Expansion of clinical program into younger children reinforces commitment to developing ...
The political uncertainty surrounding the Trump administration is viewed by ANZ as having pushed the U.S. dollar down "much further than warranted based on fundamentals", with leveraged funds now holding net short positions in the greenback for the first time since May 2016. The weakness in the world's reserve currency comes despite the Federal Reserve hiking rates in June, the possibility of further increases, and the shrinking of the Fed's balance sheet "relatively soon". ANZ's head of Asian research Khoon Goh reckons "sentiment looks to have turned too bearish, in our view".
DBV Technologies Reports First Half 2017 Financial Results. DBV Technologies today reported first half 2017 financial results. The interim financial report is available on the Investor Relations section ...
May 22, 2017 Dennis Gartman is editor and publisher of The Gartman Letter, and strategic advisor of the AdvisorShares Gartman Currency Hedged Gold ETFs (GEUR & GYEN). He regularly contributes to AlphaBaskets and lends his institutional insight to ...